Comorbidity in context : Part 1. Medical considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa

Show simple item record

dc.contributor.author Rossouw, Theresa M.
dc.contributor.author Boswell, Michael T.
dc.contributor.author Nienaber, A.G. (Annelize Gertruida)
dc.contributor.author Moodley, K.
dc.date.accessioned 2021-03-24T14:04:07Z
dc.date.available 2021-03-24T14:04:07Z
dc.date.issued 2020-07
dc.description.abstract Infectious diseases pandemics have devastating health, social and economic consequences, especially in developing countries such as South Africa. Scarce medical resources must often be rationed effectively to contain the disease outbreak. In the case of COVID-19, even the best-resourced countries will have inadequate intensive care facilities for the large number of patients needing admission and ventilation. The scarcity of medical resources creates the need for national governments to establish admission criteria that are evidence-based and fair. Questions have been raised whether infection with HIV or tuberculosis (TB) may amplify the risk of adverse COVID-19 outcomes and therefore whether these conditions should be factored in when deciding on the rationing of intensive care facilities. In light of these questions, clinical evidence regarding inclusion of these infections as comorbidities relevant to intensive care unit admission triage criteria is investigated in the first of a two-part series of articles. There is currently no evidence to indicate that HIV or TB infection on their own predispose to an increased risk of infection with SARS-CoV-2 or worse outcomes for COVID-19. It is recommended that, as for other medical conditions, validated scoring systems for poor prognostic factors should be applied. A subsequent article examines the ethicolegal implications of limiting intensive care access of persons living with HIV or TB. en_ZA
dc.description.department Immunology en_ZA
dc.description.department Public Law en_ZA
dc.description.librarian am2021 en_ZA
dc.description.uri http://www.samj.org.za en_ZA
dc.identifier.citation Rossouw, T.M., Boswell, M.T., Nienaber, A.G. et al. 2020, 'Comorbidity in context : Part 1. Medical considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa', South African Medical Journal, vol. 110, no. 7, pp. 621-624. en_ZA
dc.identifier.issn 0256-9574 (print)
dc.identifier.issn 2078-5135 (online)
dc.identifier.other 10.7196/SAMJ.2020.v110i7.14856
dc.identifier.uri http://hdl.handle.net/2263/79079
dc.language.iso en en_ZA
dc.publisher Health and Medical Publishing Group en_ZA
dc.rights © 2019, South African Medical Association. This article is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). en_ZA
dc.subject Coronavirus disease 2019 (COVID-19) en_ZA
dc.subject COVID-19 pandemic en_ZA
dc.subject Human immunodeficiency virus (HIV) en_ZA
dc.subject South Africa (SA) en_ZA
dc.subject Tuberculosis (TB) en_ZA
dc.subject Comorbidity en_ZA
dc.subject Medical considerations
dc.title Comorbidity in context : Part 1. Medical considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record